From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. HIV/AIDS>
  4. Archives

HIV/AIDS: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

 to   
Items 1-10 of 1854 are shown

SUMMARY AND COMMENT

Recycling Enfuvirtide: Possible Clinical Benefit

Salvage therapy that included enfuvirtide appeared to show a survival benefit in a small, uncontrolled, retrospective study of HIV-positive patients who had already experienced virologic failure on an enfuvirtide-containing regimen.

SUMMARY AND COMMENT

Metabolic Effects of Switching from Lopinavir/Ritonavir to Atazanavir/Ritonavir

In a small randomized trial, nondiabetic lopinavir/r users with at least one metabolic complication experienced significantly better improvements on several metabolic parameters if they switched to ritonavir-boosted atazanavir than if they did not switch.

SUMMARY AND COMMENT

Why Do Some Patients Participate in HIV Clinical Trials?

A patient’s trust in his or her physician was a strong predictor of willingness to participate in clinical studies.

SUMMARY AND COMMENT

PEPFAR in Sub-Saharan Africa: Effects on HIV-Related Outcomes

An analysis of PEPFAR’s effectiveness in 12 African countries reveals a significant decrease in the number of HIV-related deaths, but not in HIV prevalence.

SUMMARY AND COMMENT

Rifampin-Resistant TB During Boosted PI Therapy in HIV Patients

In New York City, three HIV patients with tuberculosis developed rifampin resistance after being switched to boosted PI therapy and alternate-day rifabutin.

SUMMARY AND COMMENT

Clinical Effectiveness of HBV Vaccination in HIV-Positive Patients

In an observational cohort study that showed a high incidence of hepatitis B virus infection after HIV diagnosis, HBV vaccination was effective only in a subgroup with HBV surface antibody titers ≥10 IU/L.

ANTIRETROVIRAL ROUNDS

Should We Mess with Success?Free

Should the regimens be changed for three patients who have undetectable viral loads and normal or near-normal CD4-cell counts and are tolerating their treatments well?

SUMMARY AND COMMENT

HIV Viremia Linked with Lymphoma Risk in ART-Treated Patients

The more time that antiretroviral-treated patients had detectable viremia, the higher their risk for developing lymphoma, regardless of their CD4-cell counts.

CORRECTION

Addendum: Does More HIV Testing Identify More New HIV Cases?Free

An addendum to a summary published on May 22, 2009

SUMMARY AND COMMENT

MRSA Colonization and Infection in HIV-Infected Patients

The increased rate of MRSA colonization in HIV-infected patients probably explains their elevated rate of MRSA skin and soft-tissue infections.

Items 1-10 of 1854 are shown
 to   

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?





Copyright © 2009. Massachusetts Medical Society. All rights reserved.